The impact of dose/time modification in irinotecan- and oxaliplatin-based chemotherapies on outcomes in metastatic colorectal cancer

被引：0
|
作者：
Goro Nakayama
Chie Tanaka
Keisuke Uehara
Naoki Mashita
Naomi Hayashi
Daisuke Kobayashi
Mitsuro Kanda
Suguru Yamada
Tsutomu Fujii
Hiroyuki Sugimoto
Masahiko Koike
Shuji Nomoto
Michitaka Fujiwara
Yuich Ando
Yasuhiro Kodera
机构：
[1] Nagoya University Graduate School of Medicine,Department of Gastroenterological Surgery (Surgery II)
[2] Nagoya University Graduate School of Medicine,Department of Surgical Oncology (Surgery I)
[3] Nagoya University Hospital,Department of Clinical Oncology and Chemotherapy
来源：
Cancer Chemotherapy and Pharmacology | 2014年 / 73卷
关键词：
Colorectal cancer; Relative dose intensity; Dose index; Time index;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：847 / 855
页数：8
相关论文
共 50 条
  • [41] Oxaliplatin-based Chemotherapy in Patients Aged 75 Years or Older with Metastatic Colorectal Cancer
    Fukuchi, Minoru
    Ishibashi, Keiichiro
    Tajima, Yusuke
    Okada, Norimichi
    Yokoyama, Masaru
    Chika, Noriyasu
    Hatano, Satoshi
    Matsuzawa, Takeaki
    Kumamoto, Kensuke
    Kumagai, Youichi
    Baba, Hiroyuki
    Mochiki, Erito
    Ishida, Hideyuki
    ANTICANCER RESEARCH, 2013, 33 (10) : 4627 - 4630
  • [42] A phase II trial of S-1 monotherapy in metastatic colorectal cancer after failure of irinotecan- and oxaliplatin-containing regimens
    Jeung, H-C
    Rha, S. Y.
    Cho, B. C.
    Yoo, N. C.
    Roh, J. K.
    Roh, W. J.
    Chung, H. C.
    Ahn, J. B.
    BRITISH JOURNAL OF CANCER, 2006, 95 (12) : 1637 - 1641
  • [43] Antibiotics Improve the Treatment Efficacy of Oxaliplatin-Based but Not Irinotecan-Based Therapy in Advanced Colorectal Cancer Patients
    Imai, Hiroo
    Saijo, Ken
    Komine, Keigo
    Yoshida, Yuya
    Sasaki, Keiju
    Suzuki, Asako
    Ouchi, Kota
    Takahashi, Masahiro
    Takahashi, Shin
    Shirota, Hidekazu
    Takahashi, Masanobu
    Ishioka, Chikashi
    JOURNAL OF ONCOLOGY, 2020, 2020
  • [44] Impact of irinotecan and oxaliplatin on overall survival in patients with metastatic colorectal cancer (MCRC): A population-based study
    Lim, H. J.
    Fitzgerald, C.
    Gill, S.
    Melosky, B.
    Speers, C.
    Barnett, J.
    Kennecke, H.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [45] A phase II trial of S-1 monotherapy in metastatic colorectal cancer after failure of irinotecan- and oxaliplatin-containing regimens
    H-C Jeung
    S Y Rha
    B C Cho
    N C Yoo
    J K Roh
    W J Roh
    H C Chung
    J B Ahn
    British Journal of Cancer, 2006, 95 : 1637 - 1641
  • [46] THIRD-LINE WEEKLY DOCETAXEL CHEMOTHERAPY IN ADVANCED GASTRIC CANCER WHO FAILED PREVIOUS FLUOROPYRIMIDINE AND IRINOTECAN OR OXALIPLATIN-BASED CHEMOTHERAPIES
    Lee, G. J.
    Hong, Y. S.
    Roh, S. Y.
    ANNALS OF ONCOLOGY, 2014, 25
  • [47] Sarcoidosis Associated with Oxaliplatin-Based Chemotherapy for Colorectal Cancer
    Choi, Ji Hoon
    Shin, Jung A.
    Park, Hye Kyeong
    Kim, Su Young
    Jung, Hoon
    Lee, Sung-Soon
    Lee, Hye Ran
    Koo, Hyeon-Kyoung
    CASE REPORTS IN ONCOLOGICAL MEDICINE, 2014, 2014
  • [48] Potential role of PIN1 genotypes in predicting benefit from oxaliplatin-based and irinotecan-based treatment in patients with metastatic colorectal cancer
    Mitsukuni Suenaga
    Marta Schirripa
    Shu Cao
    Wu Zhang
    Dongyun Yang
    Chiara Cremolini
    Sara Lonardi
    Francesca Bergamo
    Yang Ning
    Noriko Yamamoto
    Satoshi Okazaki
    Martin D. Berger
    Yuji Miyamoto
    Roel Gopez
    Afsaneh Barzi
    Toshiharu Yamaguchi
    Sebastian Stintzing
    Volker Heinemann
    Fotios Loupakis
    Alfredo Falcone
    Heinz-Josef Lenz
    The Pharmacogenomics Journal, 2018, 18 : 623 - 632
  • [49] Potential role of PIN1 genotypes in predicting benefit from oxaliplatin-based and irinotecan-based treatment in patients with metastatic colorectal cancer
    Suenaga, Mitsukuni
    Schirripa, Marta
    Cao, Shu
    Zhang, Wu
    Yang, Dongyun
    Cremolini, Chiara
    Lonardi, Sara
    Bergamo, Francesca
    Ning, Yang
    Yamamoto, Noriko
    Okazaki, Satoshi
    Berger, Martin D.
    Miyamoto, Yuji
    Gopez, Roel, Jr.
    Barzi, Afsaneh
    Yamaguchi, Toshiharu
    Stintzing, Sebastian
    Heinemann, Volker
    Loupakis, Fotios
    Falcone, Alfredo
    Lenz, Heinz-Josef
    PHARMACOGENOMICS JOURNAL, 2018, 18 (05): : 623 - 632
  • [50] Reply: Oxaliplatin- or irinotecan-based chemotherapy for metastatic colorectal cancer in the elderly
    Aparicio, T
    Mitry, E
    Ezenfis, J
    Dominguez, S
    BRITISH JOURNAL OF CANCER, 2004, 90 (10) : 2051 - 2052
12345